Activation of Gαq-coupled signaling pathways in glomerular podocytes promotes renal injury

Journal of the American Society of Nephrology

Volumn 16, Issue 12, 2005, Pages 3611-3622

  Wang, Liming ^a   Fields, Timothy A ^a   Pazmino, Kathy ^a   Dai, Qunsheng ^b   Burchette, James L ^a   Howell, David N ^a   Coffman, Thomas M ^a   Spurney, Robert F ^a,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; NEPHRIN; PHOSPHOLIPASE C; PODOCALYXIN; PUROMYCIN AMINONUCLEOSIDE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA;

ALBUMINURIA; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GLOMERULOPATHY; GLOMERULUS; KIDNEY INJURY; MALE; MICROSCOPY; MOUSE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; GENETICS; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; IMMUNOBLOTTING; KIDNEY DISEASE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UPREGULATION;

ALBUMINURIA; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GLOMERULAR FILTRATION RATE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; IMMUNOBLOTTING; KIDNEY DISEASES; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PODOCYTES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 33645945309     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005020167     Document Type: Article

References (66)

1. Kerjaschki D: Caught flat-footed: Podocyte damage and the molecular basis of focal glomerulosclerosis. J Clin Invest 108: 1583-1587, 2001
2. Pravenstadt H: Role of the podocyte in glomerular function. Am J Physiol 278: F173-F179, 2000
3. Somlo S, Mundel P: Getting a foothold in nephritic syndrome. Nat Genet 24: 333-335, 2000
4. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB: A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308:1801-1804, 2005
5. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349-354, 2000
6. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin 4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251-256, 2000
7. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein nephrin is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582, 1998
8. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR: TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37: 739-744, 2005
9. Stork JE, Rahman MA, Dunn MJ: Eicosanoids in experimental human renal disease. Am J Med 80: 34-45, 1986
10. Makino H, Tanaka I, Mukoyama M, Sugawara A, Mori K, Muro S, Suganami Y, Yahata K, Ishibashi R, Ocuchida S, Maruyama T, Narumiya S, Nakao K: Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. J Am Soc Nephrol 13:1757-1765, 2002
11. Lopez-Novoa J: Potential role of platelet activating factor in acute renal failure. Kidney Int 55: 1672-1682, 1999
12. Clarkson MR, McGinty A, Godson C, Brady HR: Leukotriene and lipoxins: Lipoxygenase-derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis. Nephrol Dial Transplant 13: 3043-3051, 1998
13. Sanderberg KJH: Kidney angiotensin receptors and their role in renal pathophysiology. Semin Nephrol 20: 402-416, 2000
14. Kohan DE: Endothelins in the kidney: Physiology and pathophysiology. Am J Kidney Dis 22: 493-510, 1993
15. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD: Prostanoid receptors: Subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661-690, 2001
16. Hunley TE, Kon V: Update on endothelins-Biology and clinical implications. Pediatr Nephrol 16: 752-762, 2001
17. Montrucchio G, Alloatti G, Camussi G: Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669-1699, 2000
18. Haeggstrom JZ, Wetterholm A: Enzymes and receptors in the leukotriene cascade. Cell Mol Life Sci 59: 742-753, 2002
19. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992
20. Gilbert RE, Kelly DJ, Atkins RC: Novel approaches to the treatment of progressive renal disease. Curr Opin Pharmacol 2: 183-189, 2001
21. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawar R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC b inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14: 439-447, 2000
22. Chapman DE: Calcium signaling. Cell 80: 259-268, 1995
23. Shibasaki F, Hallin U, Uchino H: Calcineurin as a multifunctional regulator. J Biochem 131:1-15, 2002
24. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228, 1998
25. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD: Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281: 1690-1693, 1998
26. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ: Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280: 574-577, 1998
27. Keys JR, Greene EA, Koch WJ, Eckhart AD: Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature. Hypertension 40: 660-666, 2002
28. Wang HG, Pathan N, Ethell IM, Krajewski S, Yamguchi Y, Shibasaki F, McKeon F, Bob T, Franke TF, Reed JC: Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284: 339-343, 1999
29. Eremina V, Wong MA, Cui S, Schwartz L, Quaggin SE: 2002. Glomerular-specific gene excision in vivo. J Am Soc Nephrol 13: 788-793, 2002
30. Moeller JM, Kovari IA, Holzman LB: Evaluation of a new tool for exploring podocyte biology: Mouse Nphs1 5′ flanking region drives LacZ expression in podocytes. J Am Soc Nephrol 11: 2306-2314, 2000
31. Kalinec F, Nazarali AJ, Hermouet S, Xu N, Gutkind JS: Mutated a subunit of Gq protein induces malignant transformation of NIH 3T3 ceUs. Mol Cell Biol 12: 4687-4693, 1992
32. Marotta CA, Wilson JT, Forget BG, Weissman SM: Human beta-globulin messenger RNA. J Biol Chem 252: 5040-5053, 1977
33. Spurney RF, Flannery J, Garner SC, Athirakul K, Liu S, Guilak F, Quarles LD: Anabolic effects of a G protein-coupled receptor kinase inhibitor expressed in osteoblasts. J Clin Invest 109: 1361-1371, 2002
34. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
35. Spurney RF, Onorato JJ, Pisetsky DS, Coffman TM: Characterization of glomerular thromboxane receptors in murine lupus nephritis. J Pharmacol Exp Ther 264: 584-590, 1993
36. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F: Cloning of rat nephrin: Expression in the developing glomeruli and in proteinuric states. Kidney Int 57: 1949-1961, 2000
37. Tendron A, Decramer S, Justrabo E, Gouyon JB, Semama DS, Gilbert T: Cyclosporin A administration during pregnancy induces a permanent nephron deficit in young rabbits. J Am Soc Nephrol 14: 3188-3196, 2003
38. Shibouta Y, Terashita ZI, Imura Y, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y: Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats. Kidney Int 39: 920-929, 1991
39. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 92: 3521-3525, 1995
40. Hirose K, Osterby R, Nozawa M, Gundersen JG: Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 21: 689-695, 1982
41. Putalla H, Soininen R, Kelpelainen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10: 1-8, 2001
42. Francois H, Athirakul K, Mao M, Rockman H, Coffman TM: Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369, 2004
43. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Harris RC, Heilig CW, Sharma K: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005
44. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS: Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286: 312-315, 1999
45. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS: CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298-1300, 2003
46. Nosaka K, Takahashi T, Nishi T, Imaki H, Suzuki T, Suzuki K, Kurokawa K, Endou H: An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity. Free Radic Biol Med 22: 597-605, 1997
47. Lombardi DM, Viswanathan M, Vio CP, Saavedra JM, Schwartz SM, Johnson RJ: Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron 87: 66-74, 2001
48. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G: Blocking angiotensin II synthesis/ activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12: 941-948, 2001
49. Puri S, Magenheimer BS, Maser RL, Ryan EM, Zien CA, Walker DD, Wallace DP, Hempson SJ, Calvet JP: Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J Biol Chem 279: 55455-55464, 2004
50. Ingulli E, Singh A, Baqi N, Amad H, Moazami S, Tejani A: Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5: 1820-1825, 1995
51. Loeffler K, Gowrishankar M, Yui V: Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome. Pediatr Nephrol 19: 281-287, 2004
52. Cayouette S, Lussier MP, Mathieu EL, Bousquet SM, Boulay G: Exocytotic insertion of TRPC6 channel into the plasma membrane upon Gq protein-coupled receptor activation. J Biol Chem 279: 7241-7246, 2004
53. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 3318: 1657-1666, 1988
54. Kreidberg JA: Podocyte differentiation and glomerulogenesis. J Am Soc Nephrol 14: 806-814, 2003
55. Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N: Angiotensin II type I receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 15: 475-1487, 2004
56. Le TH, Fogo AB, Salzler HR, Vinogradova T, Oliverio MI, Marchuk DA, Coffman TM: Modifier locus on mouse chromosome 3 for renal vascular pathology in AT1A receptordeficiency. Hypertension 43: 445-451, 2004
57. Wang L, Quarles LD, Spurney RF: Unmasking the osteoinductive effects of a G protein-coupled receptor kinase inhibitor by treatment with PTH(1-34). J Bone Miner Res 19: 1661-1670, 2004
58. Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, Hamar P, Amann K, Ritz E: Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol 15: 348-358, 2004
59. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of non-diabetic renal disease: A meta-analysis. J Am Soc Nephrol 11: 319-329, 2000
60. Chen A, Sheu LF, Chou WY, Ho YS, Lin YF, Lin FG, Lee WH: Involvement of immunopathogenic mechanisms in a spontaneously occurring glomerulopathy in mice. Nephron 78: 63-72, 1998
61. Yumura W, Sugino N, Nagasawa R, Kubo S, Hirokawa K, Maruyama N: Age-associated changes in renal glomeruli of mice. Exp Gerontol 24: 237-249, 1989
62. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen NI, Kerjaschki D, Holthofer H: Nephrin in experimental glomerular disease. Kidney Int 58: 1461-1468, 2000
63. Luimula P, Sandstrom N, Novikov D, Hothofer H: Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 82: 713-718, 2002
64. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C: Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 24: 550-560, 2004
65. Yuan H, Takeuchi E, Taylor G, Mclaughlin M, Brown D, Salant DJ: Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 13: 946-956, 2002
66. Michaud JL, Lemieux LI, Dube M, Vanderhyden BC, Robertson SJ, Kennedy CRJ: Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant α-actinin-4. J Am Soc Nephrol 14: 1200-1211, 2003